Homocysteine deteriorates intrahepatic derangement and portal-systemic collaterals in cirrhotic rats

Clinical Science

Volumn 131, Issue 1, 2017, Pages 69-86

  Tung, Hung Chun ^a   Hsu, Shao Jung ^a,b   Tsai, Ming Hung ^c   Lin, Te Yueh ^b   Hsin, I Fang ^a,b   Huo, Te Ia ^a,b   Lee, Fa Yauh ^a,b   Huang, Hui Chun ^a,b   Ho, Hsin Ling ^a,b   Lin, Han Chieh ^a,b   Lee, Shou Dong ^a,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d CHENG HSIN GENERAL HOSPITAL   (Taiwan)

Author keywords

Angiogenesis; Homocysteine; Liver cirrhosis; Liver fibrosis; Portal hypertension; Vascular responsiveness

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ARGIPRESSIN; BILIRUBIN; COLLAGEN TYPE 1; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN KINASE B; THIOACETAMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; COLLAGEN; VASCULOTROPIN A;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILIARY CIRRHOSIS; BILIRUBIN BLOOD LEVEL; BLOOD VESSEL REACTIVITY; COLLAGEN FIBER; COMMON BILE DUCT; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; EXPERIMENTAL LIVER CIRRHOSIS; HYPERHOMOCYSTEINEMIA; LIVER CIRCULATION; LIVER PERFUSION; MALE; NONHUMAN; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SPLENORENAL SHUNT; THIOACETAMIDE-INDUCED LIVER FIBROSIS; UPREGULATION; VASOCONSTRICTION; ANIMAL; GENETICS; HEPATIC PORTAL VEIN; HUMAN; LIVER; LIVER CIRRHOSIS; METABOLISM; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ARGININE VASOPRESSIN; COLLAGEN; ENDOTHELIN-1; HOMOCYSTEINE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; NITRIC OXIDE SYNTHASE TYPE III; PLATELET-DERIVED GROWTH FACTOR; PORTAL VEIN; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85014003967     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20160470     Document Type: Article

References (59)

1. Hernandez-Guerra, M., Garcia-Pagan, J.C. and Bosch, J. (2005) Increased hepatic resistance: a new target in the pharmacologic therapy of portal hypertension. J. Clin. Gastroenterol. 39, S131-S137.
2. Iwakiri, Y., Shah, V. and Rockey, D.C. (2014) Vascular pathobiology in chronic liver disease and cirrhosis-current status and future directions. J. Hepatol. 61, 912-924.
3. Lee, F.Y., Albillos, A., Colombato, L.A. and Groszmann, R.J. (1992) The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology 16, 1043-1048.
4. Sitzmann, J.V., Li, S.S. and Lin, P.W. (1989) Prostacyclin mediates splanchnic vascular response to norepinephrine in portal hypertension. J. Surg. Res. 47, 208-211.
5. Chan, C.C., Lee, F.Y., Wang, S.S., Chang, F.Y., Lin, H.C., Chu, C.J., Tai, C.C., Lai, I.N. and Lee, S.D. (1999) Effects of vasopressin on portal-systemic collaterals in portal hypertensive rats: role of nitric oxide and prostaglandin. Hepatology 30, 630-635.
6. Hellstrom, M., Gerhardt, H., Kalen, M., Li, X., Eriksson, U., Wolburg, H. and Betsholtz, C. (2001) Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis. J. Cell Biol. 153, 543-553.
7. Jain, R.K. (2003) Molecular regulation of vessel maturation. Nat. Med. 9, 685-693.
8. Iwakiri, Y., Shah, V. and Rockey, D.C. (2014) Vascular pathobiology in chronic liver disease and cirrhosis-current status and future directions. J. Hepatol. 61, 912-924.
9. Finkelstein, J.D. (1990) Methionine metabolism in mammals. J. Nutr. Biochem. 1, 228-237.
10. Ueland, P.M., Refsum, H., Stabler, S.P., Malinow, M.R., Andersson, A. and Allen, R.H. (1993) Total homocysteine in plasma or serum: methods and clinical applications. Clin. Chem. 39, 1764-1779
11. Malinow, M.R. (1994) Homocysteine and arterial occlusive diseases. J. Intern. Med. 236, 603-617.
12. Ungvari, Z. and Koller, A. (2001) Homocysteine reduces smooth muscle [Ca2+]i and constrictor responses of isolated arterioles. J. Cardiovasc. Pharmacol. 37, 705-712.
13. Wang, S., Wright, G., Harrah, J., Touchon, R., McCumbee, W., Geng, W., Fultz, M.E., Abdul-Jalil, M.N. and Wright, G.L. (2000) Short-term exposure to homocysteine depresses rat aortic contractility by an endothelium-dependent mechanism. Can. J. Physiol. Pharmacol. 78, 500-506.
14. Tawakol, A., Omland, T., Gerhard, M., Wu, J.T. and Creager, M.A. (1995) Hyperhomocysteinemia is associated with impaired endothelium-dependent vasodilatation in humans. Circulation 95, 1119-1121.
15. de Andrade, C.R., Fukada, S.Y., Olivon, V.C., de Godoy, M.A., Haddad, R., Eberlin, M.N., Cunha, F.Q., de Souza, H.P., Laurindo, F.R. and de Oliveira, A.M. (2006) Alpha1D-adrenoceptor-induced relaxation on rat carotid artery is impaired during the endothelial dysfunction evoked in the early stages of hyperhomocysteinemia. Eur. J. Pharmacol. 543, 83-91.
16. Bonaventura, D., Tirapelli, C.R., Haddad, R., Höehr, N.F., Eberlin, M.N. and de Oliveira, A.M. (2004) Chronic methionine load-induced hyperhomocysteinemia enhances rat carotid responsiveness for angiotensin II. Pharmacology 70, 91-99.
17. Ungvari, Z., Pacher, P., Rischak, K., Szollar, L. and Koller, A. (1999) Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler. Thromb. Vasc. Biol. 19, 1899-1904.
18. Chow, K., Cheung, F., Lao, T.T. and O.K., T.T. (1999) Effect of homocysteine on the production of nitric oxide in endothelial cells. Clin. Exp. Pharmacol. Physiol. 26, 817-818.
19. Upchurch, Jr, G.R., Welch, G.N., Fabian, A.J., Freedman, J.E., Johnson, J.L., Keaney, Jr, J.F. and Loscalzo, J. (1997) Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J. Biol. Chem. 272, 17012-17017.
20. Chambers, J.C., McGregor, A., Jean-Marie, J. and Kooner, J.S. (1998) Acute hyperhomocysteinaemia and endothelial dysfunction. Lancet 351, 36-37.
21. Celotto, A.C., Fukada, S.Y., Laurindo, F.R., Haddad, R., Eberlin, M.N. and de Oliveira, A. (2009) Chronic hyperhomocysteinemia impairs vascular function in ovariectomized rat carotid arteries. Amino Acids 38, 1515-1522.
22. Stamler, J.S., Osborne, J.A., Jaraki, O., Rabbani, L.E., Mullins, M., Singel, D. and Loscalzo, J. (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Invest. 91, 308-318.
23. Roybal, C.N., Yang, S., Sun, C.W., Hurtado, D., Vander Jaqt, D.L., Townes, T.M. and Abcouwer, S.F. (2004) Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J. Biol. Chem. 279, 14844-14852.
24. Maeda, M., Yamamoto, I., Fujio, Y. and Azuma, J. (2003) Homocysteine induces vascular endothelial growth factor expression in differentiated THP-1 macrophages. Biochim. Biophys. Acta 1623, 41-46.
25. Lee, I., Lee, H., Kim, J.M., Chae, E.H., Kim, S.J. and Chang, N. (2007) Short-term hyperhomocysteinemia-induced oxidative stress activates retinal glial cells and increases vascular endothelial growth factor expression in rat retina. Biosci. Biotechnol. Biochem. 71, 1203-1210.
26. Hajjar, K.A. (2001) Homocysteine: a sulph'rous fire. J. Clin. Invest. 107, 663-664.
27. Oosterbaan, A.M., Steegers, E.A. and Ursem, N.T. (2012) The effects of homocysteine and folic acid on angiogenesis and VEGF expression during chicken vascular development. Microvasc. Res. 83, 98-104.
28. Nagai, Y., Tasaki, H., Miyamoto, M., Nihei, S., Kobayashi, K., Yamashita, K., Tsutsui, M., Kouzuma, R., Okazaki, M. and Nakashima, Y. (2002) Plasma level of homocysteine is inversely-associated with the development of collateral circulation in patients with single-vessel coronary artery disease. Circ. J. 66, 158-162.
29. Duan, J., Murohara, T., Ikeda, H., Sasaki, K., Shintani, S., Akita, T., Shimada, T. and Imaizumi, T. (2000) Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia. Arterioscler. Thromb. Vasc. Biol. 20, 2579-2585.
30. Franco, D., Gigou, M., Szekely, A.M. and Bismuth, H. (1979) Portal hypertension after bile duct obstruction. Effect of the bile diversion on portal pressure in the rat. Arch. Surg. 114, 1064-1067.
31. Cameron, G.R. and Hasan, S.M. (1958) Disturbances of structure and function in the liver as the result of biliary obstruction. J. Pathol. Bacteriol. 75, 33-49.
32. Kountouras, J., Billing, B.H. and Scheuer, P.J. (1984) Prolonged bile duct ligation obstruction: a new experimental model of cirrhosis in the rat. Br. J. Exp. Pathol. 65, 305-311
33. Halvorsen, J.F. and Myking, A.O. (1974) The porto-systemic collateral pattern in the rat. Eur. Surg. Res. 6, 183-195.
34. Calès, P., Oberti, F., Veal, N., Fort, J., Kaassis, M., Moal, F., Aubé, C., Vuillenin, E., Pilette, C., Rifflet, H. and Trouvé, R. (1998) Splenorenal shunt blood flow by transit-time ultrasound as an index of collateral circulation in portal hypertensive rats. Hepatology 28, 1269-1274.
35. Colombato, L.A., Sabba, C., Polio, J. and Groszmann, R.J. (1991) Influence of anesthesia, postanesthetic state, and restraint on superior mesenteric arterial flow in normal rats. Am. J. Physiol. 260, G1-G6
36. Albillos, A., Colombato, L.A. and Groszmann, R.J. (1992) Vasodilatation and sodium retention in prehepatic portal hypertension. Gastroenterology 102, 931-935.
37. Hamilton, R.L., Berry, M.N., Williams, M.C. and Severinghaus, E.M. (1974) A simple and inexpensive membrane "lung" for small organ perfusion. J. Lipid Res. 15, 182-186
38. Mittal, M.K., Gupta, T.K., Lee, F.Y., Sieber, C.C. and Groszmann, R.J. (1994) Nitric oxide modulates hepatic vascular tone in normal rat liver. Am. J. Physiol. 267, G416-G422
39. Chojkier, M. and Groszmann, R.J. (1981) Measurement of portal-systemic shunting in the rat by using ?-labeled microspheres. Am. J. Physiol. 240, G371-G375
40. Hodeige, D., de Pauw, M., Eechaute, W., Weyne, J. and Heyndrickx, G.R. (1999) On the validity of blood flow measurement using colored microspheres. Am. J. Physiol. 276, H1150-H1158
41. Chuang, C.L., Huang, H.C., Chang, C.C., Lee, F.Y., Wu, J.C., Lee, J.Y., Hsieh, H.G. and Lee, S.D. (2015) Lipopolysaccharide enhanced renal vascular response to endothelin-1 through ETA overexpression in portal hypertensive rats. J. Gastroenterol. Hepatol. 30, 199-207.
42. Guerra, R.R., de Rosa Trotta, M., Aloia, T.P.A., Dagli, M.L.Z. and Hernandez-Blazquez, F.J. (2010) A novel chronic cirrhosis TAA-induced model in rats. Braz. J. Vet. Pathol. 3, 9-16
43. Kajimoto, H., Kai, H., Aoki, H., Yasuoka, S., Anegawa, T., Aoki, Y., Ueda, S., Okuda, S. and Imaizumi, T. (2012) Inhibition of eNOS phosphorylation mediates endothelial dysfunction in renal failure: new effect of asymmetric dimethylarginine. Kidney Int 81, 762-768.
44. Xuan, C., Lun, L.M., Zhao, J.X., Wang, H.W., Wang, J., Ning, C.P., Liu, Z., Zhang, B.B. and He, G.W. (2015) L-citrulline for protection of endothelial function from ADMA-induced injury in porcine coronary artery. Sci. Rep. 5, 10987.
45. Hsu, S.J., Lee, F.Y., Wang, S.S., Hsin, I.F., Lin, T.Y., Huang, H.C., Chang, C.C., Chuang, C.L., Ho, H.L., Lin, H.C. and Lee, S.D. (2015) Caffeine ameliorates hemodynamic derangements and portosystemic collaterals in cirrhotic rats. Hepatology 61, 1672-1684.
46. Garćia-Tevijano, E.R., Berasain, C., Rodríguez, J.A., Corrales, F.J., Arias, R., Martín-Duce, A., Caballería, J., Mato, J.M. and Avila, M.A. (2001) Hyperhomocysteinemia in liver cirrhosis: mechanisms and role in vascular and hepatic fibrosis. Hypertension 38, 1217-1221.
47. Lei, W., Long, Y., Li, S., Liu, Z., Zhu, F., Hou, F.F. and Nie, J. (2015) Homocysteine induces collagen I expression by downregulating histone methyltransferase G9a. PLoS One 10, e0130421.
48. Raaf, L., Noll, C., Cherifi, M.H., Samuel, J.L., Delcayre, C., Delabar, J.M., Benazzoug, Y. and Janel, N. (2011) Myocardial fibrosis and TGF-ß expression in hyperhomocysteinemic rats. Mol. Cell. Biochem. 347, 63-70.
49. Yang, Y.M. and Seki, E. (2015) TNFa in liver fibrosis. Curr. Pathobiol. Rep. 3, 253-261.
50. Li, S., Wang, Q., Tao, Y. and Liu, C. (2016) Swertiamarin attenuates experimental rat hepatic fibrosis by suppressing angiotensin II-angiotensin type 1 receptor-extracellular signal-regulated kinase signaling. J. Pharmacol. Exp. Ther. 359, 247-255.
51. Tamoiunas, A.E., Irnius, A. and Grabauskienë, V. (2003) Superior mesenteric artery flow changes in liver cirrhosis. Semin. Cardiol. 9, 53-57
52. Ungvari, Z., Csiszar, A., Edwards, J.G., Kaminski, P.M., Wolin, M.S., Kaley, G. and Koller, A. (2003) Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 23, 418-424.
53. Chien, S.J., Chen, T.C., Kuo, H.C., Chen, C.N. and Chang, S.F. (2015) Fulvic acid attenuates homocysteine-induced cyclooxygenase-2 expression in human monocytes. BMC Complement Altern. Med. 15, 61.
54. Lee, Y.S., Lee, S.J., Seo, K.W., Bae, J.U., Park, S.Y. and Kim, C.D. (2013) Homocysteine induces COX-2 expression in macrophages through ROS generated by NMDA receptor-calcium signaling pathways. Free Radical Res 47, 422-431.
55. Chen, I.S., Chen, Y.C., Chou, C.H., Chuang, R.F., Sheen, L.Y. and Chiu, C.H. (2012) Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis. J. Sci. Food Agric. 92, 1441-1447.
56. Hsin, I.F., Lee, J.Y., Huo, T.I., Lee, F.Y., Huang, H.C., Hsu, S.J., Wang, S.S., Ho, H.L., Lin, H.C. and Lee, S.D. (2016) 2-Hydroxyflavanone ameliorates mesenteric angiogenesis and portal-systemic collaterals in rats with liver fibrosis. J. Gastroenterol. Hepatol. 31, 1045-1051.
57. Culafić, D.M., Marković, M.L., Obrenović, R.Z. and Mijac, D.D. (2013) Plasma homocysteine levels in patients with liver cirrhosis. Vojnosanit. Pregl. 70, 57-60.
58. Woitas, R.P., Stoffel-Wagner, B., Poege, U. and Sauerbruch, T. (2002) Increased homocysteine in liver cirrhosis: a result of renal impairment? Clin. Chem 48, 796-797
59. Bhanji, R.A., Ma, M., Bain, V.G. and Montano-Loza, A.J. (2015) Hyperhomocysteinemia is associated with severity of cirrhosis and negative impact after liver transplantation. Liver Int 36, 696-704.